Lea Wagmann

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 18

Top Topics

Mass Spectrometry

Solid Phase Extraction

Capillary Electrophoresis

Top Venues

Drug testing and analysis

Journal of analytical toxicology

Therapeutic drug monitoring

This page only lists publications with an associated author ORCID identifier.

Publications

Fabian Frankenfeld, Lea Wagmann, Anush Abelian, Jason Wallach, Adeboye Adejare, Simon D Brandt, Markus R Meyer
In Vivo and In Vitro Metabolic Fate and Urinary Detectability of Five Deschloroketamine Derivatives Studied by Means of Hyphenated Mass Spectrometry. Metabolites 14 (5) (2024)
Fabian Frankenfeld, Lea Wagmann, Cathy M Jacobs, Markus R Meyer
Prevalence of Drugs of Abuse and Cognitive Enhancer Consumption Monitored in Grab Samples and Composite Wastewater via Orbitrap Mass Spectrometry Analysis. Molecules (Basel, Switzerland) 29 (16) (2024)
Fabian Frankenfeld, Lea Wagmann, Anush Abelian, Jason Wallach, Adeboye Adejare, Simon D Brandt, Markus R Meyer
In Vivo and In Vitro Metabolic Fate and Urinary Detectability of Five Deschloroketamine Derivatives Studied by Means of Hyphenated Mass Spectrometry. Metabolites 14 (5) (2024)
Fabian Frankenfeld, Lea Wagmann, Anush Abelian, Jason Wallach, Adeboye Adejare, Simon D Brandt, Markus R Meyer
In Vivo and In Vitro Metabolic Fate and Urinary Detectability of Five Deschloroketamine Derivatives Studied by Means of Hyphenated Mass Spectrometry. Metabolites 14 (5) (2024)
Mathias Hohl, Lucas Lauder, Özlem Sevimli, Mert Tokcan, Lea Wagmann, Felix Götzinger, Clara Schneider, Ulrich Hübner, Ulrike Lehnert, Markus R Meyer, Michael Böhm, Felix Mahfoud
Efficacy of Antihypertensive Drugs of Different Classes After Renal Denervation in Spontaneously Hypertensive Rats. Hypertension (Dallas, Tex. : 1979) (2023)
Fabian Frankenfeld, Lea Wagmann, Cathy M Jacobs, Markus R Meyer
Quantitative analysis of drugs of abuse and cognitive enhancers in influent wastewater by means of two chromatographic methods. Drug testing and analysis (2023)
Cathy M Jacobs, Lea Wagmann, Markus R Meyer
Sample Matrices for Mass Spectrometry-Based Adherence Monitoring: A Systematic Critical Review. Therapeutic drug monitoring (2023)
Selina Hemmer, Lea Wagmann, Benedikt Pulver, Folker Westphal, Markus R Meyer
In Vitro and In Vivo Toxicometabolomics of the Synthetic Cathinone PCYP Studied by Means of LC-HRMS/MS. Metabolites 12 (12) (2022)
Selina Hemmer, Lea Wagmann, Benedikt Pulver, Folker Westphal, Markus R Meyer
In Vitro and In Vivo Toxicometabolomics of the Synthetic Cathinone PCYP Studied by Means of LC-HRMS/MS. Metabolites 12 (12) (2022)
Cathy M Jacobs, Lea Wagmann, Markus R Meyer
Analytical toxicology of yew constituents in human blood and urine by liquid chromatography-high-resolution tandem mass spectrometry. Drug testing and analysis (2022)
Matthias J Richter, Lea Wagmann, Simon D Brandt, Markus R Meyer
In Vitro Metabolic Fate of the Synthetic Cannabinoid Receptor Agonists 2F-QMPSB and SGT-233 Including Isozyme Mapping and Carboxylesterases Activity Testing. Journal of analytical toxicology (2022)
Matthias J Richter, Lea Wagmann, Pierce V Kavanagh, Simon D Brandt, Markus R Meyer
In vitro metabolic fate of the synthetic cannabinoid receptor agonists (quinolin-8-yl 4-methyl-3-(morpholine-4-sulfonyl)benzoate [QMMSB]) and (quinolin-8-yl 4-methyl-3-((propan-2-yl)sulfamoyl)benzoate [QMiPSB]) including isozyme mapping and carboxylesterases activity testing. Drug testing and analysis (2022)
Selina Hemmer, Lea Wagmann, Benedikt Pulver, Folker Westphal, Markus R Meyer
In Vitro and In Vivo Toxicometabolomics of the Synthetic Cathinone PCYP Studied by Means of LC-HRMS/MS. Metabolites 12 (12) (2022)
Cathy M Jacobs, Lea Wagmann, Fabian Frankenfeld, Markus R Meyer
Clinical Toxicological Follow-Up Analysis of a Suicide Attempt Using Chloroquine. Journal of analytical toxicology (2022)
Lea Wagmann, Rebecca G Stiller, Svenja Fischmann, Folker Westphal, Markus R Meyer
Going deeper into the toxicokinetics of synthetic cannabinoids: in vitro contribution of human carboxylesterases. Archives of toxicology 96 (10) (2022)
Lea Wagmann, Sascha K Manier, Markus R Meyer
Can the Intake of a Synthetic Tryptamine be Detected Only by Blood Plasma Analysis? A Clinical Toxicology Case Involving 4-HO-MET. Journal of analytical toxicology (2021)
Matthias J Richter, Lea Wagmann, Tanja M Gampfer, Simon D Brandt, Markus R Meyer
In Vitro Metabolic Fate of the Synthetic Cannabinoid Receptor Agonists QMPSB and QMPCB (SGT-11) Including Isozyme Mapping and Esterase Activity. Metabolites 11 (8) (2021)
Aline C Vollmer, Lea Wagmann, Markus R Meyer
Toxic plants-Detection of colchicine in a fast systematic clinical toxicology screening using liquid chromatography-mass spectrometry. Drug testing and analysis (2021)